These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16530458)

  • 21. The important role for betaVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor.
    Iwasaki T; Takahashi S; Ishihara M; Takahashi M; Ikeda U; Shimada K; Fujino T; Yamamoto TT; Hattori H; Emi M
    J Hum Genet; 2004; 49(11):622-628. PubMed ID: 15459764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment.
    Lombardi P; Mulder M; van der Boom H; Frants RR; Havekes LM
    J Biol Chem; 1993 Dec; 268(35):26113-9. PubMed ID: 8253728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.
    Tat SK; Padrines M; Theoleyre S; Couillaud-Battaglia S; Heymann D; Redini F; Fortun Y
    Bone; 2006 Oct; 39(4):706-15. PubMed ID: 16750945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
    Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
    Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor.
    Zhang L; Xu M; Scotti E; Chen ZJ; Tontonoz P
    J Lipid Res; 2013 May; 54(5):1410-20. PubMed ID: 23419260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus.
    Rutledge AC; Qiu W; Zhang R; Kohen-Avramoglu R; Nemat-Gorgani N; Adeli K
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):579-85. PubMed ID: 19164805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual forms of low density lipoprotein receptors in hamster cell mutants with defects in the receptor structural gene.
    Kozarsky KF; Brush HA; Krieger M
    J Cell Biol; 1986 May; 102(5):1567-75. PubMed ID: 3517003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.
    Nassoury N; Blasiole DA; Tebon Oler A; Benjannet S; Hamelin J; Poupon V; McPherson PS; Attie AD; Prat A; Seidah NG
    Traffic; 2007 Jun; 8(6):718-32. PubMed ID: 17461796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI.
    Hu J; Zhang Z; Shen WJ; Nomoto A; Azhar S
    Biochemistry; 2011 Dec; 50(50):10860-75. PubMed ID: 22097902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KISS1R intracellular trafficking and degradation: effect of the Arg386Pro disease-associated mutation.
    Bianco SD; Vandepas L; Correa-Medina M; Gereben B; Mukherjee A; Kuohung W; Carroll R; Teles MG; Latronico AC; Kaiser UB
    Endocrinology; 2011 Apr; 152(4):1616-26. PubMed ID: 21285314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection.
    Konecsni T; Berka U; Pickl-Herk A; Bilek G; Khan AG; Gajdzig L; Fuchs R; Blaas D
    J Virol; 2009 Nov; 83(21):10922-30. PubMed ID: 19706701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactacystin increases LDL receptor level on HepG2 cells.
    Miura H; Tomoda H; Miura K; Takishima K; Omura S
    Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression.
    Yan H; Ma YL; Gui YZ; Wang SM; Wang XB; Gao F; Wang YP
    Acta Pharmacol Sin; 2014 Aug; 35(8):994-1004. PubMed ID: 25042549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A missense mutation in the low density lipoprotein receptor gene causes familial hypercholesterolemia in Sephardic Jews.
    Leitersdorf E; Reshef A; Meiner V; Dann EJ; Beigel Y; van Roggen FG; van der Westhuyzen DR; Coetzee GA
    Hum Genet; 1993 Mar; 91(2):141-7. PubMed ID: 8462973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells.
    Yoshimura A; Yoshida T; Seguchi T; Waki M; Ono M; Kuwano M
    J Biol Chem; 1987 Sep; 262(27):13299-308. PubMed ID: 3308876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.
    van Kerkhof P; Alves dos Santos CM; Sachse M; Klumperman J; Bu G; Strous GJ
    Mol Biol Cell; 2001 Aug; 12(8):2556-66. PubMed ID: 11514635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways.
    Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA
    PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.
    Liang W; Fishman PH
    J Biol Chem; 2004 Nov; 279(45):46882-9. PubMed ID: 15331590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.
    Gong Q; Keeney DR; Molinari M; Zhou Z
    J Biol Chem; 2005 May; 280(19):19419-25. PubMed ID: 15760896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
    Williams KJ; Fless GM; Petrie KA; Snyder ML; Brocia RW; Swenson TL
    J Biol Chem; 1992 Jul; 267(19):13284-92. PubMed ID: 1320015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.